Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
14 studies found for:    "Acute intermittent porphyria"
Show Display Options
RSS Create an RSS feed from your search for:
"Acute intermittent porphyria"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Observational Study of Acute Intermittent Porphyria Patients
Condition: Acute Intermittent Porphyria
Intervention:
2 Not yet recruiting Dental Health, Diet, Inflammation and Biomarkers in Patients With Acute Intermittent Porphyria(AIP)
Condition: Acute Intermittent Porphyria
Intervention:
3 Recruiting A Phase 1 Study of ALN-AS1 in Patients With Acute Intermittent Porphyria (AIP)
Condition: Acute Intermittent Porphyria
Interventions: Drug: ALN-AS1;   Drug: Sterile Normal Saline (0.9% NaCl)
4 Completed Phase I Gene Therapy Clinical Trial Using the Vector rAAV2/5-PBGD for the Treatment of Acute Intermittent Porphyria
Condition: Acute Intermittent Porphyria
Interventions: Genetic: rAAV2/5-PBGD vector dosage 1;   Genetic: rAAV2/5-PBGD vector dosage 2;   Genetic: rAAV2/5-PBGD vector dosage 3;   Genetic: rAAV2/5-PBGD vector dosage 4
5 Enrolling by invitation A Study to Evaluate Long-term Safety and Clinical Activity of ALN-AS1 in Patient With Acute Intermittent Porphyria (AIP)
Condition: Acute Intermittent Porphyria
Intervention: Drug: ALN-AS1
6 Completed Porphozym in the Treatment of Acute Attacks in AIP
Condition: Acute Intermittent Porphyria
Intervention: Drug: recombinant human porphobilinogen deaminase (Porphozym)
7 Enrolling by invitation Acute Porphyria Biomarkers
Conditions: Acute Intermittent Porphyria;   Hereditary Coproporphyria;   Variegate Porphyria
Intervention: Drug: Hemin
8 Recruiting Clinical Diagnosis of Acute Porphyria
Conditions: Hereditary Coproporphyria (HCP);   Acute Intermittent Porphyria (AIP);   Variegate Porphyria (VP)
Intervention:
9 Recruiting Controlled Trial of Panhematin in Treatment of Acute Attacks of Porphyria
Condition: Acute Porphyrias
Interventions: Biological: Panhematin;   Other: Placebo
10 Recruiting Longitudinal Study of the Porphyrias
Conditions: Acute Porphyrias;   Cutaneous Porphyrias
Intervention:
11 Recruiting Panhematin for Prevention of Acute Attacks of Porphyria Panhematin for Prevention of Acute Attacks of Porphyria
Conditions: Acute Intermittent Porphyria;   Hereditary Coproporphyria;   Variegate Porphyria
Interventions: Biological: Hemin for injection;   Other: Placebo
12 Completed Phase I/II Study of Heme Arginate and Tin Mesoporphyrin for Acute Porphyria
Condition: Porphyria
Interventions: Drug: heme arginate;   Drug: tin mesoporphyrin
13 Completed Studies in Porphyria III: Heme and Tin Mesoporphyrin in Acute Porphyrias
Condition: Porphyria
Interventions: Drug: heme arginate;   Drug: tin mesoporphyrin
14 Active, not recruiting Assessment of Intra-subject Variability in the Bioavailability of Chlorpromazine Hydrochloride
Conditions: Anti-Psychotic;   Management of Manifestations of Psychotic Disorders;   Treatment of Schizophrenia;   Control Nausea and Vomiting;   Relief of Restlessness and Apprehension Before Surgery;   Acute Intermittent Porphyria;   Adjunct in the Treatment of Tetanus;   Control Manifestations of the Manic Type of Mani-depressive Illness;   Relief of Intractable Hiccups
Intervention: Drug: Chlorpromazine Hydrochloride

Study has passed its completion date and status has not been verified in more than two years.